• LABline
  • Magazine Archive
  • Webinars
  • Whitepapers
  • eBooks
  • Videos
  • Subscribe
    • ID 332801653 © Ali Zainal Abidin Bsa | Dreamstime.com
    dreamstime_xxl_332801653
    POCT

    Study seeks rapid, paper-based test to detect cancer cells in cerebrospinal fluid

    LABline
    Oct. 18, 2024
    UCLA researchers look to create point-of-care test that can confirm diagnosis at the bedside.
    ID 317925355 © Insidestudio | Dreamstime.com
    dreamstime_xxl_317925355
    Courtesy of Bio-Rad
    eqas_spia_groupjul24_1_1
    Courtesy of Yourgene Health
    yourgene_cystic_fibrosis_base_assay_ivdr
    Courtesy of Thermo Fisher Scientific
    systems_image_phadia_250_with_family
    ID 59172499 © Penchan Pumila | Dreamstime.com
    dreamstime_xxl_59172499_1
    ID 109529341 © Chih Yuan Wu | Dreamstime.com
    dreamstime_xxl_109529341
    Diagnostics

    Quest Diagnostics introduces specimen self-collection for common genital tract infection testing at nationwide network of patient service centers

    LABline
    Oct. 16, 2024
    Service empowers discreet and more convenient access to testing and treatment for vaginitis and similar genital tract infections such as chlamydia, gonorrhea, trichomoniasis and...
    ID 26111623 © Withgod | Dreamstime.com
    dreamstime_xxl_26111623
    Diagnostics

    QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications

    LABline
    Oct. 14, 2024
    New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 instruments designed to enhance liquid biopsy workflows for cancer research.
    ID 71475 © Rob Bouwman | Dreamstime.com
    dreamstime_xxl_71475
    Hematology

    Experimental blood test improves early detection of pancreatic cancer

    LABline
    Oct. 9, 2024
    The findings pave the way for further evaluation of the test in a clinical setting, an important step toward approval as a potential diagnostic method for pancreatic cancer.
    ID 247678597 © Tom Wang | Dreamstime.com
    dreamstime_xxl_247678597
    Diagnostics

    FDA authorizes marketing of first home flu and COVID-19 combination test outside of emergency use authorities

    LABline
    Oct. 8, 2024
    This is the first over-the-counter (OTC) test that can detect influenza to be granted marketing authorization using a traditional premarket review pathway.
    ID 321890394 © Yuri Arcurs | Dreamstime.com
    dreamstime_xxl_321890394
    ID 248170390 © Planetfelicity | Dreamstime.com
    dreamstime_xxl_248170390
    Diagnostics

    WHO approves first mpox diagnostic test for emergency use, boosting global access

    LABline
    Oct. 4, 2024
    Early diagnosis of mpox enables timely treatment and care, and control of the virus.
    ID 329098663 © Serghei Starus | Dreamstime.com
    dreamstime_xxl_329098663
    Diagnostics

    AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer

    LABline
    Oct. 4, 2024
    Ovarian cancer is the fifth most common cause of cancer deaths among women in the United States.
    ID 210293490 © Microgen | Dreamstime.com
    dreamstime_xxl_210293490
    Diagnostics

    Big gaps seen in home medical test use by older adults

    LABline
    Oct. 2, 2024
    People with more education and higher incomes more likely to use them, as are those who have bought a test before.
    Courtesy of QIAGEN
    2_15_introductionimage

    Diagnostics

    ID 103932308 © Tyler Olson | Dreamstime.com
    dreamstime_xxl_103932308
    ID 148278627 © Auremar | Dreamstime.com
    dreamstime_xxl_148278627
    Courtesy of the NIH
    20240923cancer
    Courtesy of Roche Diagnostics
    Analyzer cobas 6800 system operator, one of the analyzers used with new TAGS technology.
    ID 47558165 © Mark Adams | Dreamstime.com
    dreamstime_xxl_47558165
    sekisui_header
    ID 327953071 © Kateryna Chyzhevska | Dreamstime.com
    dreamstime_xxl_327953071